# Vesicle Therapeutics Inc. — Form D

Vesicle Therapeutics Inc. of NIWOT, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-14. The offering totals $1.0M, of which $800K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-04-14
- Form: D
- Accession: 0001922980-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $800K
- Remaining: $200K
- Minimum investment: $100K
- Investors: 4
- Date of first sale: 2022-04-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-441838

## Issuer

- Name: Vesicle Therapeutics Inc.
- CIK: 0001922980
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 7007 JOHNSON CIRCLE, NIWOT, CO, 80503
- Phone: 720-352-6393

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Xuedong Liu | Director | Niwot, CO |
| Donna Peak | Director | Houston, TX |
| Xuedong Liu | Executive Officer | Niwot, CO |
| Donna Peak | Executive Officer | Houston, TX |

## More

- [CIK 1922980 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1922980&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001922980-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.